arrow
M

Mary Lou Chatterton

monash university
H指数:26
被引数:4,837

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blind spots in Australian bipolar disorder surveillance: Limitations of population-based and consumer needs surveys

澳大利亚双相障碍监测中的盲点:基于人群的调查和消费者需求调查的局限性

2026-11-030
PRE
Protocol for the MyPREPED trial: hybrid type 2 effectiveness–implementation trial of a peer-delivered digital self-management tool (MyBRANCHES) for young people in Australia transitioning from early intervention in psychosis services

澳大利亚精神早期干预服务过渡期青年人群同伴支持数字自我管理工具(MyBRANCHES)混合型2类效果-实施试验的方案:MyPREPED试验

2026-10-070
OAAI
Perceived Barriers and Facilitators to Help-Seeking for Alcohol and Other Drug Use Among Australian Public Safety Personnel

澳大利亚公共安全人员寻求酒精及其他药物使用帮助的感知障碍与促进因素

2026-05-200
OAAI
Supporting Staff To Address the Physical Health of Consumers in Mental Healthcare Settings: A Modified Nominal Group Technique

支持精神医疗环境中工作人员应对消费者的身体健康:一种改良的命名小组技术

2026-01-010
OA
Addressing the unmet needs of bipolar disorder in Australia and beyond

应对澳大利亚及全球范围双相障碍的未满足需求

2025-09-120
OA
An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study

一项运动生理学家服务以提高严重精神疾病成人生活质量的有效性试验:MOVEMENT研究的方案

2025-07-110
OA
Effectiveness of Low Intensity Mental Health Support via a Telehealth Enabled Network (LISTEN) for Adults With Diabetes Distress: A Parallel Group, Pragmatic Randomized Controlled Trial

通过远程医疗支持网络(LISTEN)提供低强度心理健康支持的疗效:针对糖尿病困扰成年患者的平行组、实用性随机对照试验

2025-05-200
PRE
REPURPOSING CANDESARTAN, THE ANTIHYPERTENSIVE DRUG, FOR TREATMENT OF BIPOLAR DISORDER

将抗高血压药物坎地沙坦用于治疗双相障碍

2025-02-120
OA
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression Study

氯胺酮对焦虑的影响:来自氯胺酮治疗成人抑郁症研究的发现

2025-01-070
PRE
Cost-Utility Analysis of a School-Based Universal Program for the Prevention of Anxiety, Depression, and Substance Use: The Climate Schools Combined Trial

基于学校的预防焦虑,抑郁和物质使用的通用计划的成本效用分析: 气候学校联合试验

2024-12-050
PRE
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial (vol 223, pg 533, 2023)
2024-10-140
PRE
Evaluating the effectiveness of a multi-component lifestyle therapy program versus psychological therapy for managing mood disorders (HARMON-E): protocol of a randomised non-inferiority trial

评估多成分生活方式干预方案与心理治疗在情绪障碍管理中的疗效:一项随机非劣效性试验的方案设计

2024-10-031
OAAI